Hematological diseases: Prototypical conditions requiring the diagnostic and prognostic use of molecular data

Kaaren K. Reichard, Curtis A. Hanson

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The field of diagnostic hematopathology is dynamic and evolving given the ongoing accumulation of molecular information and demand for integration of this information into routine clinical practice. In light of this molecular revolution, the appropriate and effective utilization of molecular studies by clinicians/pathologists is of paramount importance to the current diagnosis, prognosis, and monitoring of nearly all hematologic diseases. In the routine workup of certain hematologic neoplasms, it is more pertinent and practical to understand the purpose of these analyses and how to generally apply them to particular diseases rather than trying to remember a likely outdated list of genes. We will see advances in the treatment of hematologic malignancies as drug development catches up to our molecular understanding of diseases.

Original languageEnglish (US)
Pages (from-to)382-392
Number of pages11
JournalSeminars in Diagnostic Pathology
Volume30
Issue number4
DOIs
StatePublished - Nov 2013

Fingerprint

Hematologic Diseases
Hematologic Neoplasms
Pharmaceutical Preparations
Genes
Therapeutics
Pathologists

Keywords

  • Algorithm
  • Cost-effective
  • Hematologic
  • Strategy
  • Test ordering
  • Test utilization

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Hematological diseases : Prototypical conditions requiring the diagnostic and prognostic use of molecular data. / Reichard, Kaaren K.; Hanson, Curtis A.

In: Seminars in Diagnostic Pathology, Vol. 30, No. 4, 11.2013, p. 382-392.

Research output: Contribution to journalArticle

@article{7c7f60df422a45a7a16e8136bca5b15d,
title = "Hematological diseases: Prototypical conditions requiring the diagnostic and prognostic use of molecular data",
abstract = "The field of diagnostic hematopathology is dynamic and evolving given the ongoing accumulation of molecular information and demand for integration of this information into routine clinical practice. In light of this molecular revolution, the appropriate and effective utilization of molecular studies by clinicians/pathologists is of paramount importance to the current diagnosis, prognosis, and monitoring of nearly all hematologic diseases. In the routine workup of certain hematologic neoplasms, it is more pertinent and practical to understand the purpose of these analyses and how to generally apply them to particular diseases rather than trying to remember a likely outdated list of genes. We will see advances in the treatment of hematologic malignancies as drug development catches up to our molecular understanding of diseases.",
keywords = "Algorithm, Cost-effective, Hematologic, Strategy, Test ordering, Test utilization",
author = "Reichard, {Kaaren K.} and Hanson, {Curtis A.}",
year = "2013",
month = "11",
doi = "10.1053/j.semdp.2013.11.006",
language = "English (US)",
volume = "30",
pages = "382--392",
journal = "Seminars in Diagnostic Pathology",
issn = "0740-2570",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Hematological diseases

T2 - Prototypical conditions requiring the diagnostic and prognostic use of molecular data

AU - Reichard, Kaaren K.

AU - Hanson, Curtis A.

PY - 2013/11

Y1 - 2013/11

N2 - The field of diagnostic hematopathology is dynamic and evolving given the ongoing accumulation of molecular information and demand for integration of this information into routine clinical practice. In light of this molecular revolution, the appropriate and effective utilization of molecular studies by clinicians/pathologists is of paramount importance to the current diagnosis, prognosis, and monitoring of nearly all hematologic diseases. In the routine workup of certain hematologic neoplasms, it is more pertinent and practical to understand the purpose of these analyses and how to generally apply them to particular diseases rather than trying to remember a likely outdated list of genes. We will see advances in the treatment of hematologic malignancies as drug development catches up to our molecular understanding of diseases.

AB - The field of diagnostic hematopathology is dynamic and evolving given the ongoing accumulation of molecular information and demand for integration of this information into routine clinical practice. In light of this molecular revolution, the appropriate and effective utilization of molecular studies by clinicians/pathologists is of paramount importance to the current diagnosis, prognosis, and monitoring of nearly all hematologic diseases. In the routine workup of certain hematologic neoplasms, it is more pertinent and practical to understand the purpose of these analyses and how to generally apply them to particular diseases rather than trying to remember a likely outdated list of genes. We will see advances in the treatment of hematologic malignancies as drug development catches up to our molecular understanding of diseases.

KW - Algorithm

KW - Cost-effective

KW - Hematologic

KW - Strategy

KW - Test ordering

KW - Test utilization

UR - http://www.scopus.com/inward/record.url?scp=84890204563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890204563&partnerID=8YFLogxK

U2 - 10.1053/j.semdp.2013.11.006

DO - 10.1053/j.semdp.2013.11.006

M3 - Article

C2 - 24342292

AN - SCOPUS:84890204563

VL - 30

SP - 382

EP - 392

JO - Seminars in Diagnostic Pathology

JF - Seminars in Diagnostic Pathology

SN - 0740-2570

IS - 4

ER -